Y
Yongchun Shen
Researcher at Eisai
Publications - 43
Citations - 1196
Yongchun Shen is an academic researcher from Eisai. The author has contributed to research in topics: Thiostrepton & Triterpene. The author has an hindex of 16, co-authored 43 publications receiving 1032 citations. Previous affiliations of Yongchun Shen include Rice University & École supérieure de chimie physique électronique de Lyon.
Papers
More filters
Journal ArticleDOI
Macrocyclic ketone analogues of halichondrin B.
Wanjun Zheng,Boris M. Seletsky,Monica Palme,Paul J. Lydon,Lori A. Singer,Charles E. Chase,Charles-André Lemelin,Yongchun Shen,Davis Heather,Lynda Tremblay,Murray J. Towle,Kathleen A. Salvato,Bruce F. Wels,Kimberley K. Aalfs,Yoshito Kishi,Bruce A. Littlefield,Melvin J. Yu +16 more
TL;DR: Structurally simplified macrocyclic ketone analogues of halichondrin B were prepared by total synthesis and found to retain the potent cell growth inhibitory activity in vitro, stability in mouse serum, and in vivo efficacy of the natural product.
Journal ArticleDOI
Novel small molecule inhibitors of TLR7 and TLR9: mechanism of action and efficacy in vivo
Marc Lamphier,Wanjun Zheng,Eicke Latz,Mark Spyvee,Hans J. Hansen,Jeffrey Rose,Melinda Genest,Hua Yang,Christina J. Shaffer,Zhao Yan J,Yongchun Shen,Carrie Liu,Diana Liu,Thorsten R. Mempel,Christopher Rowbottom,Jesse Chow,Natalie C. Twine,Melvin J. Yu,Fabian Gusovsky,Sally T. Ishizaka +19 more
TL;DR: Very different structural classes of molecules can inhibit endosomal TLRs by essentially identical mechanisms of action, suggesting a general mechanism for targeting this group of TLRs.
Journal ArticleDOI
Discovery of Anticancer Agents of Diverse Natural Origin.
A. Douglas Kinghorn,Esperanza J. Carcache de Blanco,David M. Lucas,H. Liva Rakotondraibe,Jimmy Orjala,Djaja D. Soejarto,Djaja D. Soejarto,Nicholas H. Oberlies,Cedric J. Pearce,Mansukh C. Wani,Brent R. Stockwell,Joanna E. Burdette,Steven M. Swanson,James R. Fuchs,Mitchell Phelps,Lihui Xu,Xiaoli Zhang,Yongchun Shen +17 more
TL;DR: Several promising biologically active lead compounds from each major organism class investigated are described, and these may be seen to be representative of a very wide chemical diversity.
Patent
Macrocyclic compounds useful as pharmaceuticals
Roch Boivin,Kenichi Chiba,Jesse Chow,Hong Du,Yoshihito Eguchi,Masanori Fujita,Masaki Goto,Fabian Gusovsky,Jean-Christophe Harmange,Atsushi Inoue,Yimin Jiang,Megumi Kawada,Takatoshi Kawai,Yoshiyuki Kawakami,Akifumi Kimura,Makoto Kotake,Yoshikazu Kuboi,Charles-André Lemelin,Xiang-Yi Li,Tomohiro Matsushima,Yoshiharu Mizui,Kenzo Muramoto,Hideki Sakurai,Yongchun Shen,Hiroshi Shirota,Mark Spyvee,Isao Tanaka,John Wang,Satoshi Yamamoto,Naoki Yoneda +29 more
TL;DR: In this article, the present invention provides compounds having formula (I), and additionally provides methods for the synthesis thereof and method for the use thereof in the treatment of various disorders including inflammatory or autoimmune disorders, and disorders involving malignancy or increased angiogenesis, wherein R1 -R11, t, X, Y, Z, and n are as defined as defined in this paper.
Journal ArticleDOI
Natural product libraries to accelerate the high-throughput discovery of therapeutic leads.
Tyler A. Johnson,Tyler A. Johnson,Johann Sohn,Wayne D. Inman,Samarkand A. Estee,Steven T. Loveridge,Helene C. Vervoort,Karen Tenney,Junke Liu,Kenny K. H. Ang,Joseline Ratnam,Walter M. Bray,Nadine C. Gassner,Yongchun Shen,R. Scott Lokey,James H. McKerrow,Kyria Boundy-Mills,Arif Nukanto,Atit Kanti,Heddy Julistiono,Leonardus B.S. Kardono,Leonard F. Bjeldanes,Phillip Crews +22 more
TL;DR: The results highlight the advantages of applying modern methods in natural products-based research to accelerate the HT discovery of therapeutic leads and/or new molecular structures using LC-MS-UV-ELSD-based libraries.